Kleinschnitz C - Search Results

1

Expression of K2P5.1 potassium channels on CD4+ T lymphocytes correlates with disease activity in rheumatoid arthritis patients.

Bittner S, Bobak N, Feuchtenberger M, Herrmann AM, Göbel K, Kinne RW, Hansen AJ, Budde T, Kleinschnitz C, Frey O, Tony HP, Wiendl H, Meuth SG. Bittner S, et al. Among authors: kleinschnitz c. Arthritis Res Ther. 2011 Feb 11;13(1):R21. doi: 10.1186/ar3245. Arthritis Res Ther. 2011. PMID: 21314928 Free PMC article.

2

The contribution of TWIK-related acid-sensitive K+-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons.

Meuth SG, Aller MI, Munsch T, Schuhmacher T, Seidenbecher T, Meuth P, Kleinschnitz C, Pape HC, Wiendl H, Wisden W, Budde T. Meuth SG, et al. Among authors: kleinschnitz c. Mol Pharmacol. 2006 Apr;69(4):1468-76. doi: 10.1124/mol.105.020594. Epub 2006 Jan 19. Mol Pharmacol. 2006. PMID: 16424077

3

T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression.

Kleinschnitz C, Hofstetter HH, Meuth SG, Braeuninger S, Sommer C, Stoll G. Kleinschnitz C, et al. Exp Neurol. 2006 Aug;200(2):480-5. doi: 10.1016/j.expneurol.2006.03.014. Epub 2006 May 3. Exp Neurol. 2006. PMID: 16674943

4

Immunotherapeutic approaches in MS: update on pathophysiology and emerging agents or strategies 2006.

Kleinschnitz C, Meuth SG, Kieseier BC, Wiendl H. Kleinschnitz C, et al. Endocr Metab Immune Disord Drug Targets. 2007 Mar;7(1):35-63. doi: 10.2174/187153007780059414. Endocr Metab Immune Disord Drug Targets. 2007. PMID: 17346203 Review.

5

[Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis].

Kleinschnitz C, Meuth SG, Kieseier BC, Wiendl H. Kleinschnitz C, et al. Nervenarzt. 2007 Aug;78(8):883-911. doi: 10.1007/s00115-007-2261-9. Nervenarzt. 2007. PMID: 17551708 Review. German.

6

Multiple sclerosis therapy: an update on recently finished trials.

Kleinschnitz C, Meuth SG, Stüve O, Kieseier B, Wiendl H. Kleinschnitz C, et al. J Neurol. 2007 Nov;254(11):1473-90. doi: 10.1007/s00415-007-0684-7. Epub 2007 Nov 15. J Neurol. 2007. PMID: 18004638 Review.

7

The trials and errors in MS therapy.

Kleinschnitz C, Meuth SG, Wiendl H. Kleinschnitz C, et al. Int MS J. 2008 Sep;15(3):79-90. Int MS J. 2008. PMID: 18808741 Review.

8

The neuroprotective impact of the leak potassium channel TASK1 on stroke development in mice.

Meuth SG, Kleinschnitz C, Broicher T, Austinat M, Braeuninger S, Bittner S, Fischer S, Bayliss DA, Budde T, Stoll G, Wiendl H. Meuth SG, et al. Among authors: kleinschnitz c. Neurobiol Dis. 2009 Jan;33(1):1-11. doi: 10.1016/j.nbd.2008.09.006. Epub 2008 Sep 30. Neurobiol Dis. 2009. PMID: 18930826 Free PMC article.

9

Transient widespread blood-brain barrier alterations after cerebral photothrombosis as revealed by gadofluorine M-enhanced magnetic resonance imaging.

Stoll G, Kleinschnitz C, Meuth SG, Braeuninger S, Ip CW, Wessig C, Nölte I, Bendszus M. Stoll G, et al. Among authors: kleinschnitz c. J Cereb Blood Flow Metab. 2009 Feb;29(2):331-41. doi: 10.1038/jcbfm.2008.129. Epub 2008 Oct 29. J Cereb Blood Flow Metab. 2009. PMID: 18957988

10

Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

Multiple Sclerosis Therapy Consensus Group (MSTCG); Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R. Multiple Sclerosis Therapy Consensus Group (MSTCG), et al. J Neurol. 2008 Oct;255(10):1449-63. doi: 10.1007/s00415-008-0061-1. Epub 2008 Oct 29. J Neurol. 2008. PMID: 19005625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters